Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems
Nutrients · 30.05.2024 · 16 (11) · 1715
DOI: 10.3390/nu16111715 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 30.05.2024. Verfasst von Xiaoyuan Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The University of Hong Kong, Hong Kong 999077, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Dietary Supplements. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administration Region of China, General Research Fund, Research Grants Council, The Government of the Hong Kong Special Administrative Region.
Abstract (Originalsprache)
Diabetic retinopathy (DR) is a major vision-threatening disease among the working-age population worldwide. Present therapeutic strategies such as intravitreal injection of anti-VEGF and laser photocoagulation mainly target proliferative DR. However, there is a need for early effective management in patients with early stage of DR before its progression into the more severe sight-threatening proliferative stage. Nutraceuticals, natural functional foods with few side effects, have been proposed to be beneficial in patients with DR. Over the decades, many studies, either in vitro or in vivo, have demonstrated the advantages of a number of nutraceuticals in DR with their antioxidative, anti-inflammatory, neuroprotective, or vasoprotective effects. However, only a few clinical trials have been conducted, and their outcomes varied. The low bioavailability and instability of many nutraceuticals have indeed hindered their utilization in clinical use. In this context, nanoparticle carriers have been developed to deliver nutraceuticals and to improve their bioavailability. Despite its preclinical nature, research of interventive nutraceuticals for DR may yield promising information in their clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The University of Hong Kong, Hong Kong 999077, China.
- Department of Ophthalmology, University of British Columbia, 2550 Willow Street, Room 301, Vancouver, BC V5Z 3N9, Canada.
ORCID-Profile: Xiaoyuan Ye, Amy Cheuk Yin Lo
Förderung
- The Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administration Region of China
- General Research Fund, Research Grants Council, The Government of the Hong Kong Special Administrative Region
Zitieren
APA
Ye, X., Fung, N. S. K., Lam, W. C., & Lo, A. C. Y. (2024). Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems. Nutrients, 16(11), 1715. https://doi.org/10.3390/nu16111715
Vancouver
Ye X, Fung NSK, Lam WC, Lo ACY. Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems. Nutrients. 2024;16(11):1715. doi:10.3390/nu16111715
BibTeX
@article{Ye2024,
author = {Ye, Xiaoyuan and Fung, Nicholas Siu Kay and Lam, Wai Ching and Lo, Amy Cheuk Yin},
title = {Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {11},
pages = {1715},
doi = {10.3390/nu16111715}
}
EUVIMED